The COVID Central Academic Information System:
https://emaindia.net/home/covid_central
The Plant Base Discovery Trial
Discussion was done with the
Multi-Central Clinical Trial Team on the Progress on the Plant Based
Interventional Study. The Regulatory framework and the approval process as well
as the design was discussed.
E-Epidemiology of COVID Research
Prof. Raina presented the PubMed
Differential statistics of Published COVID Research and pointed out that CHINA
was the major producer of research when it concerned COVID19.
Analysis of Demographic and Social Determinants in Mortality
Prof. Chauhan highlighted the major
factors correlating them with open source data assessing mortality from COVID19
in the US.
Triple Cocktail Trials for Early COVID
Dr. Downing discussed the FDA
approved individual studies using Colchicine, and Motelucast for COVID19.
Chronic COVID
ECOSANOID Storm was discussed in detail
and its contributions to Chronic Inflammation, Fibrosis and Cancer was also
highlighted.
Stock Market Impact of COVID19
Dr. Tiwari and Prof. Venkat discussed the impacts of COVID19 on US-INDIA stocks and concluded that overall health care and pharma stocks did well when the whole economy suffered.
Jefferson-WACEM Sepsis Summit 2020
In September 2020 WACEM along with
Jefferson University will host the World Wide Web Summit on Sepsis 2020. It was
announced that all WACEM Members could attend the summit and participate as
speakers. Dr. David Gaieski is the Leader of this Summit.
No comments:
Post a Comment